Celecoxib/Eperisone hydrochloride - Daehwa Pharmaceutical
Alternative Names: DHP-2306Latest Information Update: 24 May 2024
Price :
$50 *
At a glance
- Originator Daehwa Pharmaceutical
- Class Analgesics; Antimigraines; Antineoplastics; Antipyretics; Antirheumatics; Muscle relaxants; Neuroprotectants; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Piperidines; Propiophenones; Pyrazoles; Small molecules; Sulfonamides; Vasodilators
- Mechanism of Action Calcium channel antagonists; Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Musculoskeletal pain
Most Recent Events
- 16 May 2024 Chemical structure information added
- 02 May 2024 Daehwa Pharmaceuticals completes enrollment in phase I trial in Musculoskeletal pain (In volunteers) in South Korea (PO) (NCT06395155)
- 07 Dec 2023 Daehwa Pharmaceutical completes a phase I trial in Musculoskeletal pain (In volunteers) in South Korea (PO) (NCT06395155)